Edition:
United States

Rosetta Genomics Ltd (ROSG.OQ)

ROSG.OQ on NASDAQ Stock Exchange Capital Market

2.55USD
11:34am EDT
Change (% chg)

$-0.07 (-2.67%)
Prev Close
$2.62
Open
$2.60
Day's High
$2.69
Day's Low
$2.43
Volume
7,235
Avg. Vol
26,151
52-wk High
$13.56
52-wk Low
$1.42

ROSG.OQ

Chart for ROSG.OQ

About

Rosetta Genomics Ltd. is engaged in developing and commercializing new diagnostic tests based on various genomics markers, including deoxyribonucleic acid (DNA), micro ribonucleic acid (microRNA) and protein biomarkers and using various technologies, including, Quantitative polymerase chain reaction (qPCR), microarrays, Next... (more)

Overall

Beta: 0.81
Market Cap(Mil.): $6.23
Shares Outstanding(Mil.): 2.38
Dividend: --
Yield (%): --

Financials

  ROSG.OQ Industry Sector
P/E (TTM): -- 213.75 15.85
EPS (TTM): -9.31 -- --
ROI: -116.88 -7.93 -8.31
ROE: -135.07 -9.29 -7.95

BRIEF-Morgan Stanley reports 5.1 pct passive stake in Rosetta Genomics

* Morgan stanley reports 5.1 percent passive stake in Rosetta Genomics as of May 23, 2017 - ‍​SEC filing Source text for Eikon: Further company coverage:

Jun 02 2017

BRIEF-Rosetta Genomics announces 1-for-12 reverse stock split

* Says ordinary shares will begin trading on a split-adjusted basis on March 17, 2017

Mar 16 2017

BRIEF-Rosetta Genomics announces U.S. patent allowances for two RosettaGX RevealTM MicroRNAs

* Rosetta Genomics announces key U.S. patent allowances for two RosettaGx RevealTM microRNAs Source text for Eikon: Further company coverage:

Feb 06 2017

Earnings vs. Estimates